| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2136219 | Journal of Bone Oncology | 2014 | 6 Pages |
Abstract
Pain flare has been established as an acute toxicity of both EBRT and SBRT, although its incidence is widely variable due to differences in data collection. The use of dexamethasone in the prophylaxis of pain flare is efficacious. Future studies are required in order to both optimize the reporting of pain and the dexamethasone regimens in the prevention of pain flare.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Rachel McDonald, Edward Chow, Leigha Rowbottom, Carlo DeAngelis, Hany Soliman,